Argenx.com

  1. Home
  2. Argenx.com

argenx Homepage

WebARGX-117. We are evaluating ARGX-117 for the treatment of severe IgM driven auto-immune diseases. ARGX-117 is designed to be a humanized sweeping antibody …

Actived: 3 days ago

URL: https://www.argenx.com/

argenx to Present at BofA Securities 2024 Health Care Conference

Webargenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, …

Category:  Health Go Health

argenx Announces Positive Phase 3 Data from ADVANCE Trial of …

Webargenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today …

Category:  Health Go Health

Patient Support Program VYVGART (efgartigimod alfa-fcab)

WebThe committed team of Case Coordinators and Nurse Case Managers at My VYVGART Path offers:. Patient-specific benefit verifications, including confirming out-of-pocket costs …

Category:  Health Go Health

Healthcare Reform

WebHealthcare Reform In the U.S., the EU and other foreign jurisdictions, there have been a number of legislative and regulatory changes to the healthcare systems that could affect …

Category:  Health Go Health

Access VYVGART (efgartigimod alfa-fcab) & VYVGART Hytrulo

WebFor commercial patients: The VYVGART Co-pay Program is for patients with commercial insurance and a valid prescription for VYVGART Hytrulo for an on-label indication; …

Category:  Health Go Health

Healthcare Law and Regulation

WebOn May 21, 2021, PhRMA sued the HHS in the U.S. District Court for the District of Columbia, to stop the implementation of the rule claiming that the rule contradicts federal …

Category:  Health Go Health

Immune Thrombocytopenia (ITP) Argenx

WebITP is a rare, often chronic bleeding disorder where reduced numbers of platelets (cells that stop or prevent bleeding) can lead to an increased risk of bleeding and bruising, and an …

Category:  Health Go Health

2019 R&D Day May 22, 2019

Web8:30 AM: argenx Today: Building Leadership in Immunology Tim Van Hauwermeiren, CEO 8:45 AM: ARGX-117: Renaissance in Complement - Therapeutic Potential of C2 Karen …

Category:  Health Go Health

Unleashing the potential of real-world evidence in rare …

WebOn 1 March 2021, argenx sponsored a panel event on the potential of RWE in rare diseases hosted by the Italian patient organisation Associazione Italiana Miastenia (AIM). Real …

Category:  Health Go Health

argenx Highlights Strategic Priorities for 2022 Argenx

Webargenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its …

Category:  Health Go Health

argenx Innovation

WebThe Immunology Innovation Program (IIP) is a core business strategy of argenx connecting the specialized insight into disease and target biology of our external scientific and …

Category:  Health Go Health

argenx Highlights 2023 Strategic Priorities Across …

WebForward Looking Statements The contents of this announcement include statements that are, or may be deemed to be, “forward-looking statements.” These forward-looking …

Category:  Health Go Health

Regulations Argenx

WebWholesale Acquisition Cost*. 73475-3102-3. VYVGART Hytrulo (efgartigimod alfa and hyaluronidase -qvfc) Solution in Vial Injection. 1,008 mg efgartigimod alfa and 11,200 …

Category:  Health Go Health

2022 Environmental, Social and Governance Report

Web2 2022 E Report Table of Contents Message from our CEO 03 The argenx Purpose 04 Our Philosophy on ESG 06 Patients 07 People 21 Governance 29 Planet 35

Category:  Health Go Health

argenx to Present at 42nd Annual J.P. Morgan Healthcare …

Webargenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, …

Category:  Health Go Health

argenx Homepage

Webargenx | Homepage - Reaching Patients Through Immunology Innovation

Category:  Health Go Health

Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in

WebPatients needed to have an MG-ADL score ≥5 (>50% from nonocular items) and needed to have a reduction in MG-ADL total score <2 points from study/cycle baseline to be eligible …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Epic health partners locations

 › Renewing health card online ontario

 › Universal health care provision statement

 › Mumbai public hospital health

 › Hcps health and dental benefits

 › Rbc wealth management health savings

 › Baptist health physical exam

 › Nuffield health personal trainer

 › Carepoint health press release

 › Staff health form daycare

Recently Searched

 › Pick your health plan medicaid

 › Texas health mesquite tx

 › Health disparities in new york

 › Jacksonville university staying healthy

 › South county mental health center jobs

 › Best practice for health literacy

 › Epic health partners martinsville

 › Jefferson county tennessee health department

 › Virginia health club contract cancellation form

 › Mental health services danville va